Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal CancerHoward L. Kaufman, Neil L. Berinstein, Heinz‐Josef Lenz et al.|Clinical Cancer Research|2008Cited by 121
A phase III trial of <i>nab</i>-paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma: A subanalysis based on <i>BRAF</i> status.Evan M. Hersh, Axel Hauschild, Caroline Robert et al.|Journal of Clinical Oncology|2013Cited by 9
Final overall survival from a phase 3 trial of <i>nab</i>-paclitaxel versus dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma.Evan M. Hersh, Axel Hauschild, Michele Del Vecchio et al.|Journal of Clinical Oncology|2014Cited by 5